SMKUY yields 45.63% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 10
Combined, SMKUY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SMKUY + PFE for your $10,000?
Siam Makro Public Company Limited operates cash and carry trade centers under the Makro name. It operates through Cash and Carry, Retail, Mall Rental, and Food Services segments. The company's trade centers sell food and non-food products to registered members, including small and medium-sized businesses, retailers, caterers, professional sectors, and institutions. It offers freight, delivery rental, and storage services; marketing and consulting services; and imports, exports, trades in, and distributes food products. The company is also involved in the provision of technical and support services; trading of non-food products; investing and operation of retail business and mall rental activities; importing and trading of frozen and chilled foods; telecommunication business; and operation of restaurant and minimart. As of December 31, 2021, it operated 135 Makro stores and 7 frozen shops. The company was incorporated in 1988 and is headquartered in Bangkok, Thailand. Siam Makro Public Company Limited is a subsidiary of CP ALL Public Company Limited.
Full SMKUY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.